(1->4)-beta-D-glucan multiple interactions ISO RGD:737241 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAPK13 mRNA CTD PMID:36331819 (S)-nicotine decreases expression ISO RGD:737241 6480464 Nicotine results in decreased expression of MAPK13 mRNA CTD PMID:17135361 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:737240 6480464 o, p'-DDT results in decreased expression of MAPK13 mRNA CTD PMID:19371625 1,2-dimethylhydrazine multiple interactions ISO RGD:737241 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAPK13 mRNA CTD PMID:22206623 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO RGD:737240 6480464 14-deoxy-11, 12-didehydroandrographolide results in decreased expression of MAPK13 mRNA CTD PMID:22101062 17alpha-ethynylestradiol increases expression ISO RGD:737241 6480464 Ethinyl Estradiol results in increased expression of MAPK13 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of MAPK13 mRNA CTD PMID:17557909 17beta-estradiol increases expression ISO RGD:737241 6480464 Estradiol results in increased expression of MAPK13 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:737240 6480464 IGF1R mutant form inhibits the reaction [Estradiol results in increased expression of MAPK13 mRNA] CTD PMID:23094148 17beta-estradiol increases expression ISO RGD:737240 6480464 Estradiol results in increased expression of MAPK13 mRNA CTD PMID:23094148 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737240 6480464 Tetrachlorodibenzodioxin results in increased expression of MAPK13 mRNA CTD PMID:23152189 2-hydroxypropanoic acid decreases expression ISO RGD:737240 6480464 Lactic Acid results in decreased expression of MAPK13 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of MAPK13 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737240 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of MAPK13 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:737241 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MAPK13 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAPK13 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO RGD:737241 6480464 Fenretinide results in increased expression of MAPK13 mRNA CTD PMID:28973697 4-nitrophenol decreases expression ISO RGD:737241 6480464 4-nitrophenol results in decreased expression of MAPK13 mRNA CTD PMID:34673133 5-fluorouracil increases expression ISO RGD:737240 6480464 Fluorouracil results in increased expression of MAPK13 protein CTD PMID:15585135 , PMID:16803524 afimoxifene decreases response to substance ISO RGD:737240 6480464 MAPK13 results in decreased susceptibility to afimoxifene CTD PMID:21233418 Aflatoxin B2 alpha increases methylation ISO RGD:737240 6480464 aflatoxin B2 results in increased methylation of MAPK13 intron CTD PMID:30157460 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAPK13 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:737240 6480464 aristolochic acid I results in increased expression of MAPK13 mRNA CTD PMID:33212167 arsenous acid increases expression ISO RGD:737240 6480464 Arsenic Trioxide results in increased expression of MAPK13 mRNA CTD PMID:29633893 azathioprine increases expression ISO RGD:737240 6480464 Azathioprine results in increased expression of MAPK13 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO RGD:737240 6480464 Benzo(a)pyrene results in increased expression of MAPK13 mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects methylation ISO RGD:737240 6480464 Benzo(a)pyrene affects the methylation of MAPK13 3' UTR, Benzo(a)pyrene affects the methylation of MAPK13 promoter CTD PMID:27901495 bis(2-chloroethyl) sulfide decreases expression ISO RGD:737241 6480464 Mustard Gas results in decreased expression of MAPK13 mRNA CTD PMID:18955075 bisphenol A decreases expression ISO RGD:737240 6480464 bisphenol A results in decreased expression of MAPK13 mRNA CTD PMID:19371625 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAPK13 mRNA CTD PMID:36041667 bisphenol A increases expression ISO RGD:737241 6480464 bisphenol A results in increased expression of MAPK13 mRNA CTD PMID:32156529 bisphenol F increases expression ISO RGD:737241 6480464 bisphenol F results in increased expression of MAPK13 mRNA CTD PMID:30951980 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAPK13 mRNA CTD PMID:36041667 butan-1-ol multiple interactions ISO RGD:737240 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MAPK13 mRNA CTD PMID:29432896 cadmium dichloride multiple interactions ISO RGD:737240 6480464 [SB 203580 co-treated with Cadmium Chloride] results in increased expression of MAPK13 mRNA CTD PMID:19757093 cadmium dichloride increases expression ISO RGD:737240 6480464 Cadmium Chloride results in increased expression of MAPK13 mRNA CTD PMID:32512071 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of MAPK13 promoter CTD PMID:22457795 calcitriol increases expression ISO RGD:737240 6480464 Calcitriol results in increased expression of MAPK13 mRNA CTD PMID:16002434 , PMID:26485663 carbamazepine affects expression ISO RGD:737240 6480464 Carbamazepine affects the expression of MAPK13 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:737241 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 choline multiple interactions ISO RGD:737241 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAPK13 mRNA CTD PMID:20938992 copper(II) sulfate increases expression ISO RGD:737240 6480464 Copper Sulfate results in increased expression of MAPK13 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:737240 6480464 Cyclosporine results in increased expression of MAPK13 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:737240 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of MAPK13 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:737240 6480464 Arsenic Trioxide results in increased expression of MAPK13 mRNA CTD PMID:29633893 dibutyl phthalate increases expression ISO RGD:737241 6480464 Dibutyl Phthalate results in increased expression of MAPK13 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:737241 6480464 Dichloroacetic Acid results in increased expression of MAPK13 mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:737240 6480464 Diclofenac affects the expression of MAPK13 mRNA CTD PMID:24752500 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of MAPK13 mRNA CTD PMID:22546817 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of MAPK13 mRNA CTD PMID:22911455 dioxygen increases expression ISO RGD:737240 6480464 Oxygen deficiency results in increased expression of MAPK13 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:737240 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:737240 6480464 Doxorubicin results in increased expression of MAPK13 mRNA CTD PMID:30031762 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MAPK13 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:737240 6480464 entinostat results in increased expression of MAPK13 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:737240 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPK13 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:737241 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAPK13 mRNA CTD PMID:30517762 folic acid multiple interactions ISO RGD:737241 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 genistein decreases expression ISO RGD:737240 6480464 Genistein results in decreased expression of MAPK13 mRNA CTD PMID:19371625 glyphosate decreases expression ISO RGD:737240 6480464 glyphosate results in decreased expression of MAPK13 mRNA CTD PMID:31295307 graphite affects expression EXP 6480464 Graphite affects the expression of MAPK13 mRNA CTD PMID:29933104 indometacin multiple interactions ISO RGD:737240 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of MAPK13 mRNA CTD PMID:28628672 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of MAPK13 mRNA CTD PMID:20097248 L-methionine multiple interactions ISO RGD:737241 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAPK13 mRNA CTD PMID:20938992 monosodium L-glutamate affects expression EXP 6480464 Sodium Glutamate affects the expression of MAPK13 mRNA CTD PMID:28954212 N-acetyl-L-cysteine multiple interactions ISO RGD:737240 6480464 Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of MAPK13 protein] CTD PMID:28087840 nickel atom increases expression ISO RGD:737240 6480464 Nickel results in increased expression of MAPK13 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MAPK13 mRNA CTD PMID:22546817 nickel sulfate decreases expression ISO RGD:737240 6480464 nickel sulfate results in decreased expression of MAPK13 mRNA CTD PMID:22714537 nicotine decreases expression ISO RGD:737241 6480464 Nicotine results in decreased expression of MAPK13 mRNA CTD PMID:17135361 ozone multiple interactions ISO RGD:737241 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MAPK13 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAPK13 mRNA CTD PMID:34911549 paclitaxel increases expression ISO RGD:737240 6480464 Paclitaxel results in increased expression of MAPK13 protein CTD PMID:15907983 panobinostat multiple interactions ISO RGD:737240 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPK13 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:737240 6480464 panobinostat results in increased expression of MAPK13 mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:737240 6480464 Acetaminophen results in increased expression of MAPK13 mRNA CTD PMID:22230336 paraquat increases expression ISO RGD:737241 6480464 Paraquat results in increased expression of MAPK13 mRNA CTD PMID:28012437 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MAPK13 mRNA CTD PMID:32680482 paricalcitol multiple interactions ISO RGD:737240 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of MAPK13 mRNA CTD PMID:17715259 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:737241 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAPK13 mRNA CTD PMID:36331819 phosphorus atom multiple interactions ISO RGD:737240 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of MAPK13 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:737240 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of MAPK13 mRNA CTD PMID:17715259 pirinixic acid multiple interactions ISO RGD:737241 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of MAPK13 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of MAPK13 mRNA] CTD PMID:17950772 , PMID:20813756 pirinixic acid increases expression ISO RGD:737241 6480464 pirinixic acid results in increased expression of MAPK13 mRNA CTD PMID:17950772 more ... pyrogallol increases expression ISO RGD:737241 6480464 Pyrogallol results in increased expression of MAPK13 mRNA CTD PMID:20362636 quercetin affects expression ISO RGD:737240 6480464 Quercetin affects the expression of MAPK13 protein CTD PMID:15221776 quercetin increases expression ISO RGD:737240 6480464 Quercetin results in increased expression of MAPK13 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:737240 6480464 Lactic Acid results in decreased expression of MAPK13 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:737240 6480464 resveratrol results in decreased expression of MAPK13 mRNA CTD PMID:19371625 SB 203580 multiple interactions ISO RGD:737240 6480464 [SB 203580 co-treated with Cadmium Chloride] results in increased expression of MAPK13 mRNA CTD PMID:19757093 SB 431542 multiple interactions ISO RGD:737240 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:737240 6480464 Silicon Dioxide analog results in increased expression of MAPK13 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:737240 6480464 sodium arsenite results in increased expression of MAPK13 mRNA CTD PMID:20886546 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MAPK13 mRNA CTD PMID:35314868 sodium arsenite multiple interactions ISO RGD:737240 6480464 sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK13 protein CTD PMID:15504454 sodium dichromate decreases expression ISO RGD:737240 6480464 sodium bichromate results in decreased expression of MAPK13 mRNA CTD PMID:17685462 sulfates affects methylation ISO RGD:737240 6480464 Sulfates affects the methylation of MAPK13 promoter CTD PMID:25395096 sunitinib increases expression ISO RGD:737240 6480464 Sunitinib results in increased expression of MAPK13 mRNA CTD PMID:31533062 tetrachloromethane multiple interactions ISO RGD:737241 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAPK13 mRNA CTD PMID:30517762 thioacetamide affects methylation EXP 6480464 Thioacetamide affects the methylation of MAPK13 promoter CTD PMID:25151969 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAPK13 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:737241 6480464 titanium dioxide results in increased expression of MAPK13 mRNA CTD PMID:27760801 titanium dioxide affects expression ISO RGD:737241 6480464 titanium dioxide affects the expression of MAPK13 mRNA CTD PMID:23557971 tris(2-butoxyethyl) phosphate affects expression ISO RGD:737240 6480464 tris(2-butoxyethyl) phosphate affects the expression of MAPK13 mRNA CTD PMID:29024780 urethane decreases expression ISO RGD:737240 6480464 Urethane results in decreased expression of MAPK13 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:737241 6480464 Valproic Acid affects the expression of MAPK13 mRNA CTD PMID:17292431 valproic acid increases methylation ISO RGD:737240 6480464 Valproic Acid results in increased methylation of MAPK13 gene CTD PMID:29501571 valproic acid multiple interactions ISO RGD:737240 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPK13 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737240 6480464 Valproic Acid results in increased expression of MAPK13 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:737240 6480464 Valproic Acid results in decreased expression of MAPK13 mRNA CTD PMID:29154799 , PMID:29501571 vancomycin decreases expression ISO RGD:737241 6480464 Vancomycin results in decreased expression of MAPK13 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of MAPK13 mRNA CTD PMID:22570695 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MAPK13 mRNA CTD PMID:23034163 zearalenone decreases expression ISO RGD:737240 6480464 Zearalenone results in decreased expression of MAPK13 mRNA CTD PMID:19371625
